Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Mar;30(3):21.
doi: 10.15844/pedneurbriefs-30-3-4.

Guidelines for Corticosteroid use in Treatment of DMD

Vamshi K Rao  1
Affiliations
Comment

Guidelines for Corticosteroid use in Treatment of DMD

Vamshi K Rao. Pediatr Neurol Briefs. 2016 Mar.

Abstract

The guideline development subcommittee of the American Academy of Neurology has provided an update to the 2005 treatment guidelines for use of corticosteroids (CS) in Duchenne muscular dystrophy (DMD).

Keywords: Corticosteroids; Duchenne muscular dystrophy; Guidelines.

PubMed Disclaimer

Comment on

References

    1. Gloss D, Moxley RT, 3rd, Ashwal S, Oskoui M. Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016 Feb;86(5):465–72. doi: 10.1212/WNL.0000000000002337. - DOI - PMC - PubMed
    1. University of Rochester. ClinicalTrials.gov [Internet] Bethesda (MD): National Library of Medicine (US); Finding the Optimum Regimen for Duchenne Muscular Dystrophy (FOR-DMD) 2000- [cited 2016 Mar 16]. Available from: http://clinicaltrials.gov/show/NCT01603407 NLM Identifier: NCT01603407.